Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2021 年第 4 季持倉
持倉截至 2021/12/31，2022/2/16 申報。只含多頭部位，變化是跟 2021 年第 3 季比股數。
- 持股檔數
- 43
- 較 2021 年第 3 季 −12
- 總值
- $2.61 億
- 較 2021 年第 3 季 −$4,218 萬 (−13.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ASNDAscendis Pharma A/S | SPONSORED ADR | 190,000 | $2,556 萬 | 9.8% | +70,000+58.3% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 325,000 | $1,537 萬 | 5.9% | +125,000+62.5% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,700,000 | $1,459 萬 | 5.6% | +200,000+13.3% | 加碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 350,000 | $1,352 萬 | 5.2% | +95,000+37.3% | 加碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 350,000 | $1,286 萬 | 4.9% | +100,000+40.0% | 加碼 | 歷史 |
| MRUSMerus N.V. | COM | 350,000 | $1,113 萬 | 4.3% | +275,000+366.7% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 625,000 | $1,045 萬 | 4.0% | −100,000−13.8% | 減碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 500,000 | $988.5 萬 | 3.8% | +150,000+42.9% | 加碼 | 歷史 |
| RCKTRocket Pharmaceuticals, Inc. | COM | 425,000 | $927.8 萬 | 3.6% | +75,000+21.4% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 110,000 | $903.5 萬 | 3.5% | −40,000−26.7% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 100,000 | $900.5 萬 | 3.4% | +100,000 | 新進 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 80,000 | $672.5 萬 | 2.6% | +15,000+23.1% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 300,000 | $656.7 萬 | 2.5% | −275,000−47.8% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 250,000 | $594.8 萬 | 2.3% | +90,000+56.3% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 500,000 | $577.5 萬 | 2.2% | +235,000+88.7% | 加碼 | 歷史 |
| SRRASierra Oncology, Inc. | COM NEW | 250,000 | $543.5 萬 | 2.1% | +50,000+25.0% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 30,000 | $508.7 萬 | 1.9% | +30,000 | 新進 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $504.0 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 200,000 | $483.0 萬 | 1.8% | +200,000 | 新進 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 325,000 | $472.6 萬 | 1.8% | +50,000+18.2% | 加碼 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 210,000 | $464.1 萬 | 1.8% | +110,000+110.0% | 加碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 200,000 | $450.6 萬 | 1.7% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 30,000 | $440.1 萬 | 1.7% | −30,000−50.0% | 減碼 | 歷史 |
| CYPHCypherpunk Technologies Inc. | COM | 1,350,000 | $437.4 萬 | 1.7% | −300,000−18.2% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 250,000 | $418.0 萬 | 1.6% | +250,000 | 新進 | 歷史 |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $406.9 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $390.0 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $382.5 萬 | 1.5% | 00.0% | 不變 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 450,000 | $362.3 萬 | 1.4% | +50,000+12.5% | 加碼 | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 118,344 | $336.2 萬 | 1.3% | −31,656−21.1% | 減碼 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 295,000 | $323.6 萬 | 1.2% | +295,000 | 新進 | 歷史 |
| NMTR9 Meters Biopharma, Inc. | COM | 3,250,000 | $318.1 萬 | 1.2% | +500,000+18.2% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 225,000 | $315.0 萬 | 1.2% | −200,000−47.1% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 100,000 | $312.4 萬 | 1.2% | −690,000−87.3% | 減碼 | 歷史 |
| CTICCti Biopharma Corp | COM | 1,200,000 | $297.6 萬 | 1.1% | −400,000−25.0% | 減碼 | 歷史 |
| DSGNDesign Therapeutics, Inc. | COM | 135,000 | $289.0 萬 | 1.1% | +135,000 | 新進 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 225,000 | $242.8 萬 | 0.9% | +25,000+12.5% | 加碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 100,000 | $233.3 萬 | 0.9% | −300,000−75.0% | 減碼 | 歷史 |
| GBTGlobal Blood Therapeutics, Inc. | COM | 60,000 | $175.6 萬 | 0.7% | +60,000 | 新進 | 歷史 |
| IMUXImmunic, Inc. | COM | 165,000 | $157.9 萬 | 0.6% | −100,000−37.7% | 減碼 | 歷史 |
| RETAReata Pharmaceuticals Inc | CL A | 55,000 | $145.0 萬 | 0.6% | +55,000 | 新進 | 歷史 |
| PRDSPardes Biosciences, Inc. | COM | 50,000 | $81.9 萬 | 0.3% | +50,000 | 新進 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 135,000 | $51.2 萬 | 0.2% | +35,000+35.0% | 加碼 | 歷史 |
選擇權（3 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2021 年第 3 季之後清倉（21 檔）
2021 年第 3 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 3 季股數 | 2021 年第 3 季市值 | 2021 年第 3 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | COM | 700,000 | $1,726 萬 | 5.7% | 歷史 |
| ALLKAllakos Inc. | COM | 85,000 | $899.9 萬 | 3.0% | 歷史 |
| ALDXAldeyra Therapeutics, Inc. | COM | 700,000 | $614.6 萬 | 2.0% | 歷史 |
| AVIRAtea Pharmaceuticals, Inc. | COM | 150,000 | $525.9 萬 | 1.7% | 歷史 |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $494.3 萬 | 1.6% | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM | 250,000 | $462.3 萬 | 1.5% | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $415.9 萬 | 1.4% | 歷史 |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $411.0 萬 | 1.4% | 歷史 |
| TCRRTCR2 Therapeutics Inc. | COM | 477,323 | $406.2 萬 | 1.3% | 歷史 |
| ALLOAllogene Therapeutics, Inc. | COM | 150,000 | $385.5 萬 | 1.3% | 歷史 |
| FATEFate Therapeutics Inc | COM | 50,000 | $296.4 萬 | 1.0% | 歷史 |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 75,000 | $287.5 萬 | 0.9% | 歷史 |
| MRNAModerna, Inc. | Stock | 5,300 | $204.0 萬 | 0.7% | 歷史 |
| ALECAlector, Inc. | COM | 80,000 | $182.6 萬 | 0.6% | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 50,000 | $141.1 萬 | 0.5% | 歷史 |
| CMRXChimerix Inc | COM | 200,000 | $123.8 萬 | 0.4% | 歷史 |
| OTICOtonomy, Inc. | COM | 450,000 | $86.4 萬 | 0.3% | 歷史 |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $77.4 萬 | 0.3% | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 2,000 | $54.6 萬 | 0.2% | 歷史 |
| TBIOTelesis Bio Inc. | COM | 35,000 | $39.0 萬 | 0.1% | 歷史 |
| PRVBProvention Bio, Inc. | COM | 50,000 | $32.0 萬 | 0.1% | 歷史 |